CXCL1 and COVID-19: Classical drug digitoxin has been shown to block cytokine storm via suppressing the levels of the cytokines TNFα, GRO/KC, MIP2, MCP1 and IFN-γ, with implications for influenza and potentially for COVID-19 (21).